Quantcast

Latest Teva Respiratory Stories

2014-03-05 08:25:34

National Campaign Seeks to Educate People with Asthma on the Importance of 'Knowing Their Count' LANDOVER, Md., March 5, 2014 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory announced today the launch of a national awareness campaign - Know Your Count - aimed at raising awareness of the seriousness of asthma and educating asthma patients and caregivers about the importance of keeping track of the remaining doses in their rescue inhalers. The...

2011-05-16 11:05:00

PHILADELPHIA, May 16, 2011 /PRNewswire/ -- The Phillies and Teva Respiratory are teaming up to raise awareness of asthma, which continues to be a widespread issue in the city of Philadelphia. For the second year in a row, Teva Respiratory is hosting Phillies Asthma Awareness Night in partnership with the American College of Allergy, Asthma and Immunology (ACAAI) on Thursday, May 19 at Citizens Bank Park, before and during the 7:05 p.m. Phillies game against the Colorado Rockies. As part...

2011-05-10 08:07:00

HORSHAM, Pa., May 10, 2011 /PRNewswire/ -- Teva Respiratory today announced results from the recently completed Nasal Allergy Survey Assessing Limitations (NASL) 2010, which found patients with allergic rhinitis (AR) who had nasal symptoms were more likely to experience sleep disturbances, including difficulty getting to sleep and/or waking up during the night. Lack of a good night's sleep can significantly impact a person's quality of life. For people living with nasal allergies in the...

2011-03-21 16:47:00

SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- Results from a recent pivotal allergic rhinitis (AR) satisfaction survey assessing patient and healthcare provider perspectives on AR reveal that symptoms like nasal congestion and post-nasal drip continue to impact patients' daily activities. Findings from the Nasal Allergy Survey Assessing Limitations (NASL) 2010, released today by Teva Respiratory at the American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting, held in San...

2010-07-28 09:45:00

HORSHAM, Pa., July 28 /PRNewswire/ -- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy endpoints, demonstrating a statistically significant benefit as compared to placebo. Furthermore, the safety profile of BDP HFA Nasal Aerosol was similar to placebo. "The outcomes of the...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related